U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07452562) titled 'Hesperidin RCT in MS' on Feb. 28.
Brief Summary: This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress.
Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
Study Start Date: Jan. 07
Study Type: INTERVENTIONAL
Condition:
Multiple Sclerosis
Intervention:
DIETARY_...